Skip to main content
. Author manuscript; available in PMC: 2019 Dec 27.
Published in final edited form as: Infect Control Hosp Epidemiol. 2019 Feb 15;40(3):276–280. doi: 10.1017/ice.2018.347

Table 3:

Utilization of C. difficile Testing Restrictions and Hospital Characteristics Relative to Hospital C. difficile Testing Strategy

Hospital Characteristic Toxin Testing* NAAT Alone# P
Restrict C. difficile testing to unformed stools 53/56 (95%) 88/95 (93%) 0.63
Age-based C. difficile testing restrictions 28/56 (50%) 47/93 (51%) 0.95
University hospital 37/60 (62%) 62/99 (63%) 0.90
Freestanding children’s hospital 35/60 (58%) 53/99 (54%) 0.56
Fewer than 350 hospital beds 39/60 (65%) 64/99 (65%) 0.97
*

Toxin Testing: Toxin test used either as a single test or part of a multi-step algorithm

#

NAAT Alone: Used either an NAAT assay that only detects C. difficile, or a multiplex PCR panel that includes C. difficile, without initial or confirmatory toxin testing